Company intelligence / Profile preview

AMI Cardiac Monitoring

United States

Ownership: Private
Development stage: Other

Overview

AMI Cardiac Monitoring offers a suite of FDA-cleared ambulatory cardiac diagnostic services, including mobile cardiac telemetry, event, and Holter monitoring, delivering continuous or event-triggered ECG data supported by clinical analysis for arrhythmia and atrial fibrillation diagnosis. The company is recognized for over 30 years of reliability and patient care in ambulatory ECG monitoring.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

WearLinq

Beyond the preview

Go deeper on AMI Cardiac Monitoring.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMI Cardiac Monitoring.

Explore the full profile